Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Sleep in Pediatric Patients With Attention Deficit/Hyperactivity Disorder, Phase II

NCT07061470 is registered in ClinicalTrials.gov with Hugo W. Moser Research Institute at Kennedy Krieger, Inc. as lead sponsor.

NCT NCT07061470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07061470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Sleep in Pediatric Patients With Attention Deficit/Hyperactivity Disorder, Phase II
Lead sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
July 31, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, sleep problems